Facilitated By

San Antonio Medical Foundation

News

  • Amgen to buy Horizon Therapeutics in $26.4B deal - MySA

    The biotech drug developer said Monday that it will pay $116.50 in cash for each ... San Antonio braces for cold temperatures to hit on Tuesday.

  • Amgen to buy Horizon Therapeutics in $26.4B deal - MyNorthwest.com

    The biotech drug developer said Monday that it will pay $116.50 in cash for each share ... Crews find 4th victim from blast at San Antonio company.

  • Texas-Squared Startup Newsletter #379 | by Marc Nathan | Dec, 2022 - Medium

    KXAN; San Antonio's Rackspace is Grappling with a Ransomware Attack — Link ... Southlake Biotech Renibus Therapeutics Garners $33M in Bridge ...

  • Angle PLC Announces Two Parsortix Posters Presented at SABCS - BioSpace

    ... at the San Antonio Breast Cancer Symposium (SABCS), in San Antonio, ... The laboratories offer services globally to pharmaceutical and biotech ...

  • New data on breast cancer candidate sends Ambrx Biopharma skyward - The Pharma Letter

    ... data from its Phase II ACE‑Breast-03 study during a Spotlight Poster Presentation at the 2022 San Antonio Breast Cancer Symposium (SABCS).